| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | FACs followed by IF staining | NA | 0.36 | 0.6448 | 21124918
|
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | CFA and SFA followed by Western Blotting | NA | 0.36 | 0.6448 | 35163585
|
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by ELISA | NA | 0.28 | 0.684 | 26088878
|
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by RT-PCR | NA | 0.28 | 0.684 | 26546046
|
| KLF4 | 6348 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | CFA and SFA followed by Western Blotting | NA | 0.28 | 0.0891 | 35163585
|
| KLF4 | 6348 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by FACs and SP assay | NA | 0.28 | 0.0891 | 30092824
|
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | CFA and SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 35163585
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | CFA and SFA followed by Western Blotting | NA | 0.28 | 0.7582 | 35163585
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by RT-PCR | NA | 0.28 | 0.7582 | 29414668
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | FACs followed by SFA | NA | 0.28 | 0.7582 | 27276704
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by FACs and SP assay | NA | 0.28 | 0.7582 | 30092824
|
| SHH | 10848 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by ELISA | NA | 0.28 | 0.0201 | 26088878
|
| ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.0604 | 17510412
|
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.1739 | 29414668
|
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.1739 | 17510412
|
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.1135 | 29414668
|
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | FACs | NA | 0.2 | 0.1135 | 21124918
|
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.5695 | 29414668
|
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by FACs and SP assay | NA | 0.2 | 0.5695 | 30092824
|
| MYC | 7553 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H441 | NA | SFA followed by FACs and SP assay | NA | 0.12 | 0.1304 | 30092824
|